Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/455
Title: No differences in perioperative outcome between symptomatic and asymptomatic AAAs after EVAR: an analysis from the ENGAGE registry.
Epworth Authors: Grigg, Michael
Other Authors: Stokmans, Rutger
Teijink, Joep
Cuypers, Philippe
Riambau, Vincent
van Stambeek, Marc
Keywords: Symptomatic Abdominal Aneurysm
Elective Non-Symptomatic AAA
Endurant Stent Graft Natural Selection Global Post-Market Registry
(ENGAGE)
(S-AAA)
(E-AAA)
Endovascular Techniques
Endovascular Repair
Endurant Stent Graft
Aneurysm
Urorenal and Vascular Clinical Institute, Epworth HealthCare
Issue Date: Jun-2012
Publisher: Elsevier Health Sciences.
Citation: European Journal of Vascular & Endovascular Surgery, 2012-06-01, Volume 43, Issue 6, Pages 667-673
Abstract: Aim This study aimed to compare the differences in perioperative outcome after endovascular repair of symptomatic abdominal aneurysms (S-AAAs) and elective non-symptomatic AAAs (E-AAAs). Data from the ENGAGE Registry were used for the analysis. Methods Between March 2009 and December 2010, 1200 AAA patients were enrolled from 79 sites in 30 countries and treated with an Endurant Stent Graft. S-AAAs defined as AAAs accompanied by abdominal or back pain, without rupture, were present in 185 (15.4%) patients and E-AAAs in 1015 (84.6%) patients. Multivariate logistic regression was used to compare results. Results At baseline, E-AAA patients had larger aneurysms on average ( P = 0.006) and scored higher ASA classification more often ( P = 0.001). Further analyses were corrected for baseline differences. Operation time and technical success were comparable, and S-AAAs were admitted to the Intensive Care Unit (ICU) as often as E-AAAs (35.7% vs. 33.4%, P = 0.479). Post-operative hospitalisation was similar (4.83 ± 5.29 in E-AAAs and 4.37 ± 3.49 in S-AAAs, P = 0.360). No differences in the occurrence of major adverse events, including mortality, within the 30-day post-implantation were seen between S-AAA and E-AAA patients, respectively, 3.2% and 4.2% ( P = 0.572). Conclusion With contemporary devices and technical proficiency, there is no difference in outcome between symptomatic AAA and elective non-symptomatic AAA patients if treated with endovascular techniques.
Description: Prof Michael Grigg, Eastern Epworth HealthCare, is a participant in ENGAGE (Endurant Stent Graft Natural Selection Global Post-market) Registry.
URI: http://hdl.handle.net/11434/455
DOI: 10.1016/j.ejvs.2012.02.034
PubMed URL: http://www.ncbi.nlm.nih.gov/pubmed/22440235
ISSN: 1078-5884
1532-2165
Journal Title: European Journal of Vascular and Endovascular Surgery.
Type: Journal Article
Type of Clinical Study or Trial: Meta-Analysis
Appears in Collections:UroRenal, Vascular

Files in This Item:
There are no files associated with this item.


Items in EKB are protected by copyright, with all rights reserved, unless otherwise indicated.